ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 114382 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 114382; 2) Community: the network communities that were significantly associated with the response to NSC 114382; 3) Molecule: the relationships between components within communities and NSC 114382; 4) MDR: the compounds that were significantly associated with the NSC 114382.

NSC Compound Enrichment Correlation
NSC 710264 Null 0.0314734733353265 0.46435503
NSC 715224 Null 0.0314734733353265 0.32580837
NSC 732841 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3-trifluoromethylbenzene 0.0314734733353265 0.27547712
NSC 753790 6-Imino-1,2,3,4,8,9,10,11-octahydropyrido[1,2-a]pyrido[1',2',1,2]imidazo[5,4-f]benzimidazol-13-one 0.0314734733353265 -0.065702832
NSC 13479 Null 0.0376362543535811 0.077113402
NSC 174121 Methotrexate Derivative 0.0376362543535811 0.43339191
NSC 274556 Null 0.0376362543535811 0.3812328
NSC 382001 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(2,5-dimethyl phenyl)-, hydrochloride 0.0376362543535811 0.43312248
NSC 617824 Null 0.0376362543535811 0.40539785
NSC 647638 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) 0.0376362543535811 0.0093488165
Total:47  Current:33    [First] [Prev] [Next] [Last]